Pharma & Bio
Lifestyle
Boehringer Ingelheim Considers Direct Investment in K-Bio... “Discussions Underway for Follow-On Investments in Korean Companies” [only-EDAILY]
Global pharmaceutical giant Boehringer Ingelheim is expected to expand its investments in and technology acquisitions from Korean biotech companies through its venture fund. In particular, it has been…
Technology
BIODYNE CO., LTD.’s ‘EarlyPop’ Passes EU MDR Conformity Assessment… Shipments to Russia and Vietnam Imminent
Earlypap®, a self-collection brush for cervical cancer screening developed by BIODYNE CO., LTD.(314930), has passed the European Medical Device Regulation (MDR) conformity assessment, bringing the com…
Lifestyle
'KOSDAQ Promotion-Demotion System Overhaul Imminent'…All Eyes on Hugel, Inc., CLASSYS Inc., and Pharmaresearch
With the restructuring of the KOSDAQ market’s promotion-demotion system imminent, interest is growing in which companies will be included in the so-called “Premier League” (Premium Group), which will …
Lifestyle
ADBIOTECH Co.,Ltd. Soars on Rights Offering and Corporate Restructuring… Prestige Rises on CDMO Expectations [Bio Spotlight]
On the 25th, the domestic pharmaceutical sector showed a generally weak performance. The pharmaceutical sector index fell 0.45% from the previous day. Out of a total of 160 stocks, 34 rose, 13 remaine…
Lifestyle
[BioUSA] 10 Billion Won in Revenue Through Genomic Technology… The Competitive Edge of InnoCrass, Backed by Samsung, HYUNDAI BIOSCIENCE CO., LTD., KOLON CORPORATION, and Big Pharma
There is an unlisted biotech venture in which #Samsung, #HYUNDAI BIOSCIENCE CO., LTD., and KOLON CORPORATION(002020)have invested, and which has signed supply contracts with global Big Pharma companie…
Technology
Yuhan Corporation and HK inno.N Corporation Break Through Generic Drug Limitations and Improve Business Structure [Bio in Numbers ②]
Among domestic pharmaceutical companies, those that consistently prove their worth through solid financial results (numbers) are drawing attention. In the past, pharmaceutical companies were stuck in …
Lifestyle
Choi Ho-jun, CEO of Wise birds Inc.: “We Will Lead the Way in Creating K-Bio Blockbusters”
South Korea’s pharmaceutical, biotech, and healthcare industries are accelerating their global expansion. Recently, products such as Zimpentra ( Celltrion(068270)) and Cenobamate ( SK BIOPHARMACEUTICA…
Lifestyle
GC Biopharma Corp.: Why Its Stock Price Is Falling Despite the Sale of Curevo… When Will It Start to Rise Again?
GCGreen Cross Corporation(006280)has continued its downward trend since announcing the sale of its stake in Curevo. Although the stock price has rebounded slightly over the past few days, analysts say…
Technology
The Unsung Heroes of K-Beauty: Aesthetic Clinics… Characteristics of Companies with High Profit Margins [Bio Series with Numbers, Part 4]
K-Aesthetics (cosmetic medicine) is at the heart of sectors where South Korea leads the global market. We have entered an era where the cash-generating power of a single wrinkle-smoothing injection or…
Technology
"From a Dream to 100 Billion Won in Operating Profit"... The Keys to Strong Performance in New Drugs and Platforms [Bio: The Numbers Speak for Themselves ③]
“Has entered Phase 2 clinical trials,” “Has signed a contract with a global pharmaceutical company”Just a year ago, a single line like this was enough to double a biotech company’s stock price. But no…